Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

被引：0
|
作者：
Simone Gerzeli
Carla Rognoni
Silvana Quaglini
Maria Caterina Cavallo
Giovanni Cremonesi
Alberto Papi
机构：
[1] University of Pavia,Department of Political and Social Sciences
[2] University of Pavia,Laboratory for Biomedical Informatics, Department of Computer Engineering and Systems Science
[3] Bocconi University,Centre for Research on Health and Social Care Management (CERGAS)
[4] Chiesi Farmaceutici S.p.A.,Research Centre on Asthma and COPD
[5] University of Ferrara,undefined
来源：
Clinical Drug Investigation | 2012年 / 32卷
关键词：
Asthma; National Health Service; Probabilistic Sensitivity Analysis; Asthma Management; Successful Control;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Asthma is a chronic disease characterized by acute symptomatic episodes with variable severity and duration. Pharmacological asthma management aims to achieve and maintain control without side effects, thus improving quality of life and reducing the economic impact. Recently, a clinical trial showed the non-inferiority of beclomethasone/formoterol (BDP/F) versus fluticasone propionate/salmeterol (FP/S) in adults with moderate to severe persistent asthma. However, this study did not provide evidence on costs and did not quantify quality-of-life parameters.
引用
收藏
页码：253 / 265
页数：12
相关论文
共 50 条
  • [41] Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma
    David I Bernstein
    Kevin R Murphy
    Hendrik Nolte
    Allergy, Asthma & Clinical Immunology, 6 (Suppl 2)
  • [42] Comparison of salmeterol/fluticasone propionate (FP) combination with FP plus sustained release theophylline in moderate asthma patients
    Adachi, Mitsuru
    Aizawa, Hisamichi
    Ishihara, Kyousuke
    Ohta, Ken
    Sano, Yasuyuki
    Taniguchi, Hiroyuki
    Nakashima, Mitsuyoshi
    RESPIRATORY MEDICINE, 2008, 102 (07) : 1055 - 1064
  • [43] Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
    Sullivan, Patrick W.
    Li, Qianyi
    Bilir, S. Pinar
    Dang, Joseph
    Kavati, Abhishek
    Yang, Ming
    Rajput, Yamina
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 23 - 32
  • [44] Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials
    Wickstrom, Jannie
    Dam, Nanna
    Malmberg, Irena
    Hansen, Brian Bekker
    Lange, Peter
    CLINICAL RESPIRATORY JOURNAL, 2009, 3 (03): : 169 - 180
  • [45] Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids
    Alexander Chuchalin
    Loretta Jacques
    Lucy Frith
    Clinical Drug Investigation, 2008, 28 : 169 - 181
  • [46] Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland
    Tamminen, Klaus
    Laine, Juha
    Soini, Erkki
    Martikainen, Janne
    Kankaanranta, Hannu
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3453 - 3461
  • [47] An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
    Sullivan, S. D.
    Turk, F.
    ALLERGY, 2008, 63 (06) : 670 - 684
  • [48] Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma
    Pearlman, DS
    Peden, D
    Condemi, JJ
    Weinstein, S
    White, M
    Baitinger, L
    Scott, C
    Ho, SY
    House, K
    Dorinsky, P
    JOURNAL OF ASTHMA, 2004, 41 (08) : 797 - 806
  • [49] Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma
    Li, Hong-tao
    Zhang, Tian-tuo
    Zhou, Hong
    Qu, Xiu-Juan
    Wu, Wei-Ming
    Huang, Jin
    RESPIRATION, 2007, 74 (01) : 33 - 43
  • [50] Comparison of high-dose salmeterol/fluticasone and moderate-dose salmeterol/fluticasone plus low-dose mometasone in patients with severe persistent asthma
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    Takayanagi, Noboru
    Sugita, Yutaka
    RESPIROLOGY, 2011, 16 (05) : 784 - 789
12345